Back
Speaker illustration

Professor Udo Bavendiek

Hannover Medical School, Hannover (Germany)

Member of:

Heart Failure Association

Presentations Articles

DIGIT­HF: Baseline characteristics compared to recent trials in heart failure with reduced ejection fraction

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Hottest trials and trial updates (2)

Access
Like
Thumbnail

Digitoxin serum concentrations affecting patient safety and potential outcome in patients with HFrEF - analyses of the ongoing DIGIT-HF-trial

Event: ESC Congress 2017

Topic: Pharmacologic therapy

Session: Chronic heart failure (CHF)

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources